MELINDA WINIKUR: Open Payments
NPI 1023567724 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 58 payments from 16 companies in 2025. Trend: 2023 $1,132 · 2024 $1,270 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $218 |
| Novo Nordisk Inc | 9 | $194 |
| PFIZER INC. | 5 | $97 |
| Abbott Laboratories | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| Lundbeck LLC | 3 | $57 |
| Lilly USA, LLC | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| Amgen Inc. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: NURTEC ODT, Ozempic, QULIPTA, FREESTYLE LIBRE 3, VRAYLAR, UBRELVY, VYEPTI, MOUNJARO.
Industry payments across VA — which companies pay providers there.
